EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.14.99.1 | Sus scrofa | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.14.99.1 | uterine endometrium | - |
Sus scrofa | - |
1.14.99.1 | uterus | - |
Sus scrofa | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.99.1 | arachidonate + AH2 + O2 | - |
Sus scrofa | prostaglandin H2 + A + H2O | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.14.99.1 | cyclooxygenase 2 | - |
Sus scrofa |
1.14.99.1 | PG G/H synthase 2 | - |
Sus scrofa |
1.14.99.1 | prostaglandin-endoperoxide synthase 2 | - |
Sus scrofa |
1.14.99.1 | PTGS2 | - |
Sus scrofa |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.14.99.1 | heme | - |
Sus scrofa |
EC Number | Organism | Comment | Expression |
---|---|---|---|
1.14.99.1 | Sus scrofa | 0.1 and 0.001 mM lysophosphatidic acid increases PTGS2 mRNA abundance in the uterine endometrium, the lysophosphatidic acid-induced increase of PTGS2 expression is reduced by cotreatment with Ki-16425 | up |